Clinical data | |
---|---|
Trade names | Fasigyn, Simplotan, Tindamax |
AHFS/Drugs.com | Monograph |
MedlinePlus | a604036 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | 12% |
Metabolism | Liver (CYP3A4) |
Elimination half-life | 12–14 hours |
Excretion | Urine (20–25%), feces (12%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
NIAID ChemDB | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.039.089 |
Chemical and physical data | |
Formula | C8H13N3O4S |
Molar mass | 247.27 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Tinidazole, sold under the brand name Tindamax among others, is a medication used against protozoan infections. It is widely known throughout Europe and the developing world as a treatment for a variety of anaerobic amoebic and bacterial infections. It was developed in 1972 and is a prominent member of the nitroimidazole antibiotic class.[2]
It is on the World Health Organization's List of Essential Medicines.[3]